These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 321205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1978 Oct; 16(4):273-301. PubMed ID: 359311
    [Abstract] [Full Text] [Related]

  • 3. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.
    Wilde MI, Benfield P.
    Drugs; 1995 Mar; 49(3):411-39. PubMed ID: 7774514
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the cardiovascular toxicity of three tricyclic antidepressant drugs: imipramine, amitriptyline, and doxepin.
    Brown TC, Leversha A.
    Clin Toxicol; 1979 Mar; 14(3):253-6. PubMed ID: 455914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Doxepin hydrochloride.
    Hollister LE.
    Ann Intern Med; 1974 Sep; 81(3):360-3. PubMed ID: 4604347
    [No Abstract] [Full Text] [Related]

  • 10. Which tricyclic for depressed outpatients, imipramine pamoate or amitriptyline?
    Goldberg HL, Finnerty RJ.
    Dis Nerv Syst; 1977 Oct; 38(10):785-9. PubMed ID: 332472
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.
    Marshall JB, Forker AD.
    Am Heart J; 1982 Mar; 103(3):401-14. PubMed ID: 7039280
    [No Abstract] [Full Text] [Related]

  • 12. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K, Csanalosi I, Werblowsky J, Weise CC, Weinstock R, Brown AS, Winokur A, Von Poelnitz M.
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [Abstract] [Full Text] [Related]

  • 13. Doxepin versus amitriptyline in depression: a sequential double-blind study.
    Grof P, Saxena B, Cantor R, Daigle L, Hetherington D, Haines T.
    Curr Ther Res Clin Exp; 1974 May; 16(5):470-6. PubMed ID: 4209062
    [No Abstract] [Full Text] [Related]

  • 14. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC, Morley PA, Brogden RN, Carmine AA, Speight TM, Avery GS.
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [Abstract] [Full Text] [Related]

  • 15. Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1979 Jul; 18(1):1-24. PubMed ID: 477572
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC, Huey LY, Janowsky DS.
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P, Heel RC, Lewis SP.
    Drugs; 1986 Dec; 32(6):481-508. PubMed ID: 2878798
    [Abstract] [Full Text] [Related]

  • 18. Family practice management of depression: how to select tricyclic antidepressants.
    Simmons EC.
    South Med J; 1979 Jun; 72(6):703-4. PubMed ID: 451657
    [No Abstract] [Full Text] [Related]

  • 19. Excess fatality from desipramine in children and adolescents.
    Amitai Y, Frischer H.
    J Am Acad Child Adolesc Psychiatry; 2006 Jan; 45(1):54-60. PubMed ID: 16327581
    [Abstract] [Full Text] [Related]

  • 20. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
    Rickels K, Feighner JP, Smith WT.
    Arch Gen Psychiatry; 1985 Feb; 42(2):134-41. PubMed ID: 2858187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.